Skip to content

All Zoomed Out and Nothing to Apply For?

There’s got to be something you can apply for during this time when we’re stuck and not able to be in the lab as much as we’d like. I’ve rounded up a few links, in case you missed them. I separated them into four categories, because it’s actually pretty confusing. 1) New NIH Covid-related submissions 2) $ for adding a Covid twist to existing research 3) FOAs that aren’t directly related to Covid but have exended application dates and 4) New Covid-related NSF funding. So, no more excuses, there is definitely something to apply for. Right now. And…. (a little humor for those as sick of Zoom as I am).

1) Rolling Submission New Covid Opportunities

On May 6th, NIAID released two “New R01, R21 Pair of COVID-19 Emergency FOAs With Rolling Submission. The two FOAs are ideal for applicants proposing new coronavirus-related research projects. They feature rolling submission, meaning you can submit an application as soon as it is ready and NIAID will review it in an expedited fashion.” Hooray for rolling submission. It’s exactly what we need in these unpredictable times, when everyone is scattered and having to work over Zoom or whatever.

2) Special Covid-related Supplements, Including for Behavioral Sciences

The NIH also released this Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences. Here’s what they are looking for:
“This NOSI encourages urgent competitive supplements and administrative supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts, including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health.” Notice Number: NOT-OD-20-097

As far as I understood, you can ask for money to tack on research related to Covid to ongoing longitudinal studies on other, related topics.

3) NIAID Released Emergency Covid NOSI:

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). This NOSI “highlight[s] the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. NIAID is therefore offering Competitive Revisions to active NIAID grants addressing research objectives described below.”

4) List of Delayed Funding Calls

NIH/NIGMS announced on May 5th that they were delaying many deadlines until June 2020. All of the funding calls listed here are now due June 30th (see bottom of newsletter for list). Not a ton of time, but better than a kick in the teeth, as my mother would say!

5) NSF Rapid Response Research Funding

NSF encourages the research community to respond to this challenge through existing funding opportunities. In addition, we invite researchers to use the Rapid Response Research (RAPID) funding mechanism, which allows NSF to receive and review proposals having a severe urgency with regard to availability of or access to data, facilities or specialized equipment as well as quick-response research on natural or anthropogenic disasters and similar unanticipated events. Requests for RAPID proposals may be for up to $200K and up to one year in duration. Well-justified proposals that exceed these limits may be entertained. All questions should be directed either to a program officer managing an NSF program with which the research would be aligned or to [email protected]. Proposals in response to this DCL may also request the use of NSF-funded.
PAR-19-367 “Maximizing Investigators’ Research Award (R35 – Clinical Trial Optional)”

PAR-20-102 “IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)”

PAR-19-219 Maximizing Access to Research Careers (T34)

PAR-19-218 Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)

PAR-19-102 Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)

PAR-17-341 National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32)

PAR-19-036 Medical Scientist Training Program (T32)

PAR-20-041 Support of Competitive Research (SCORE) Research Continuance Award (SC3 – Clinical Trial Not Allowed)

PAR-20-040 Support of Competitive Research (SCORE) Pilot Project Award (SC2 – Clinical Trial Not Allowed)

PAR-20-039 Support of Competitive Research (SCORE) Research Advancement Award (SC1 – Clinical Trial Not Allowed)

PAR-20-104 Biomedical Technology Development and Dissemination Center (RM1 – Clinical Trial Not Allowed)

PAR-20-103 Collaborative Program Grant for Multidisciplinary Teams (RM1 – Clinical Trial Optional)

PAR-20-115 Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III – Transitional Centers (P30 Clinical Trial Optional)

Back To Top